Research Briefing | Aug 12, 2021

Australia | It’s a race: reopening waiting on vaccine rollout

Copy of Ipad Frame (38)

The protracted Greater Sydney lockdown, and return to lockdown conditions in other capital cities and regions has led to a marked downgrade in our forecasts for 2021. Uncertainty abounds, with the highly transmissible Delta strain of the coronavirus making suppression strategies very difficult to achieve and increasing the chance of future outbreaks.

Download this comprehensive 5-page report to learn:

  • Federal and state governments have put forward guidance on how future outbreaks will be navigated. In NSW, vaccination rate targets will be a prerequisite for reopening the economy. However, social distancing and travel restrictions will be tighter than previously envisaged until vaccination milestones are reached.
  • Vaccination rates have increased sharply in recent weeks. We present upside and downside scenarios on the future path of new vaccinations to benchmark when restrictions could be relaxed. We expect it will take until mid-late Q4 before the 80% vaccination target for those over 16 years old will be met.
  • The reimposition of restrictions has led to a sharp downgrade in our consumption forecasts, while the expected recovery in services trade has also been pushed out. Work stoppages in construction will also weigh on GDP in Q3.
Tags: AustraliaCoronavirusCoronavirus vaccineRecoveryVaccines
Back to Resource Hub

Related Services

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

The ruling Liberal Democratic Party's (LDP) landslide election victory on Sunday doesn't change our expectation of a primary fiscal deficit of 2%-3% of GDP in FY2026-FY2028 – we still see the deficit only starting to decline from FY2029. We also keep our view that the 10-year Japanese government bond (JGB) yield will be at 2.3% at end-2026 and 2.5% at end-2027 and beyond.
US and Chinese strength won’t boost all other economies

US and Chinese strength won’t boost all other economies

Upward revisions to US and Chinese GDP growth in Q4 meant that the previously anticipated soft end to 2025 failed to materialise.